Y-29794 | m-entrepreneurship.com

Product Name :
Y-29794

Search keywords :
Y-29794

drugId :
null

Target Vo:
Prolyl endopeptidase

Target Vo Short Name :
PEP

Moa_Name:
Prolyl endopeptidase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Mitsubishi Pharma Corp

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Cognition Disorders

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD9 Rabbit mAb web
MyD88 Rabbit mAb site
CARD9 Antibody: CARD9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to CARD9. It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts